Sangamo Therapeutics Income Statement (2009-2025) | SGMO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2009	Jun2009	Sep2009	Dec2009	Mar2010	Jun2010	Sep2010	Dec2010	Mar2011	Jun2011	Sep2011	Dec2011	Mar2012	Jun2012	Sep2012	Dec2012	Mar2013	Jun2013	Sep2013	Dec2013	Mar2014	Jun2014	Sep2014	Dec2014	Mar2015	Jun2015	Sep2015	Dec2015	Mar2016	Jun2016	Sep2016	Dec2016	Mar2017	Jun2017	Sep2017	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue	3.16M	4.73M	4.06M	10.24M	6.65M	6.53M	2.94M	4.69M	2.20M	1.51M	1.86M	4.75M	3.24M	4.57M	4.91M	8.93M	4.62M	6.93M	5.71M	6.87M	8.12M	10.38M	12.42M	14.95M	13.49M	8.36M	8.57M	9.12M	3.94M	3.70M	2.82M	8.92M	3.42M	8.25M	11.81M	13.08M	12.64M	21.42M	23.56M	26.84M	8.07M	17.55M	21.96M	54.85M	13.08M	21.55M	57.76M	25.80M	26.28M	27.87M	28.56M		28.23M	29.38M	26.46M	27.23M	157.96M	6.83M	9.40M	2.04M	0.48M	0.36M	49.41M	6.50M	6.44M	18.31M	0.58M
Operating items
Research & Development	7.26M	6.88M	6.17M	8.69M	7.37M	7.15M	8.77M	9.87M	8.26M	8.12M	7.84M	7.88M	7.28M	7.57M	7.57M	9.28M	8.22M	9.28M	8.70M	10.84M	12.08M	13.46M	16.34M	15.09M	14.98M	15.62M	16.69M	19.91M	15.27M	19.45M	17.01M	13.89M	12.94M	14.98M	18.43M	19.38M	23.55M	29.25M	28.81M	33.25M	34.85M	36.45M	36.29M	38.33M	41.48M	41.52M	45.29M	52.36M	56.43M	60.09M	62.50M	51.80M	58.58M	60.02M	65.12M	66.18M	63.22M	63.05M	57.09M	50.71M	35.89M	24.22M	27.73M	23.68M	26.01M	27.08M	28.14M
Selling, General & Administrative	2.93M	3.01M	2.70M	3.97M	3.29M	3.26M	2.89M	3.15M	3.54M	3.68M	3.59M	3.23M	3.24M	2.74M	3.14M	3.02M	3.31M	3.12M	3.16M	4.21M	3.64M	3.97M	3.73M	4.33M	4.73M	5.02M	4.56M	4.89M	5.36M	11.09M	5.02M	4.86M	7.28M	6.04M	6.42M	7.47M	10.09M	11.30M	10.99M	14.36M	17.12M	14.60M	14.92M	15.05M	16.12M	17.93M	16.18M	16.87M	16.15M	16.49M	14.50M	16.08M	14.91M	15.09M	16.24M	16.44M	18.14M	16.01M	13.92M	13.10M	11.77M	12.04M	11.05M	9.87M	10.06M	9.08M	7.99M
Other Operating Expenses													0.00M			-0.00M																																									58.57M	51.35M	44.80M	0.30M	4.35M	1.17M
Operating Expenses	10.18M	9.88M	8.87M	12.66M	10.65M	10.40M	11.66M	13.03M	11.80M	11.79M	11.43M	11.11M	10.53M	10.32M	10.71M	12.30M	11.53M	12.40M	11.87M	15.04M	15.73M	17.43M	20.07M	19.42M	19.71M	20.64M	21.25M	24.79M	20.62M	30.54M	22.03M	18.75M	20.22M	21.02M	24.85M	26.84M	33.63M	40.56M	39.80M	47.61M	51.97M	51.05M	51.21M	53.38M	57.60M	59.45M	61.46M	69.23M	72.58M	76.57M	77.00M	67.89M	73.49M	75.11M	81.35M	82.62M	139.92M	130.41M	115.81M	64.10M	52.01M	37.44M	38.78M	33.54M	36.06M	36.16M	36.13M
Operating Income	-7.03M	-5.16M	-4.80M	-2.42M	-4.00M	-3.88M	-8.71M	-8.34M	-9.60M	-10.28M	-9.57M	-6.37M	-7.28M	-5.74M	-5.80M	-3.37M	-6.91M	-5.47M	-6.16M	-8.17M	-7.61M	-7.05M	-7.65M	-4.47M	-6.22M	-12.28M	-12.69M	-15.67M	-16.68M	-26.84M	-19.21M	-9.83M	-16.79M	-12.77M	-13.04M	-13.77M	-21.00M	-19.14M	-16.24M	-20.77M	-43.90M	-33.50M	-29.25M	1.47M	-44.52M	-37.90M	-3.70M	-43.43M	-46.30M	-48.70M	-48.44M	-39.90M	-45.26M	-45.73M	-54.89M	-55.39M	18.03M	-123.57M	-106.41M	-62.06M	-51.53M	-37.08M	10.63M	-25.99M	-29.63M	-17.86M	-35.55M
EBIT	-7.03M	-5.16M	-4.80M	-2.42M	-4.00M	-3.88M	-8.71M	-8.34M	-9.60M	-10.28M	-9.57M	-6.37M	-7.28M	-5.74M	-5.80M	-3.37M	-6.91M	-5.47M	-6.16M	-8.17M	-7.61M	-7.05M	-7.65M	-4.47M	-6.22M	-12.28M	-12.69M	-15.67M	-16.68M	-26.84M	-19.21M	-9.83M	-16.79M	-12.77M	-13.04M	-13.77M	-21.00M	-19.14M	-16.24M	-20.77M	-43.90M	-33.50M	-29.25M	1.47M	-44.52M	-37.90M	-3.70M	-43.43M	-46.30M	-48.70M	-48.44M	-39.90M	-45.26M	-45.73M	-54.89M	-55.39M	18.03M	-123.57M	-106.41M	-62.06M	-51.53M	-37.08M	10.63M	-25.99M	-29.63M	-17.86M	-35.55M
Non-operating items
Interest & Investment Income	0.19M	0.65M	-0.05M		0.03M	0.02M	0.02M		0.02M				0.01M	0.02M	0.01M		0.02M	0.02M	0.01M		0.04M	0.07M	0.11M		0.15M	0.15M	0.10M	0.03M	0.19M	0.24M	0.24M	0.22M	0.16M	0.28M	0.68M	0.68M	0.81M	2.50M	3.40M	1.55M	1.69M	3.15M	1.89M	3.03M	1.55M	1.93M	2.43M	2.87M	0.62M	1.55M	0.83M	2.34M	1.34M	2.64M	1.77M	3.68M	3.29M	2.80M	3.52M	1.49M	0.45M	0.42M	0.35M	4.64M	0.31M	0.39M	0.35M
Other Non Operating Income																																																													2.08M	0.61M	-0.22M		-1.16M	-2.49M	0.11M
Non Operating Income						0.02M	0.02M	0.02M		0.02M	0.02M	0.01M																																																	2.08M	0.61M	-0.22M		-1.16M	-2.49M	0.11M
Net income details
EBT	-6.83M	-4.51M	-4.85M	-2.42M	-3.98M	-3.86M	-8.70M	-8.34M	-9.58M	-10.28M	-9.57M	-6.37M	-7.27M	-5.73M	-5.79M	-3.37M	-6.88M	-5.45M	-6.14M	-8.17M	-7.57M	-6.98M	-7.54M	-4.32M	-6.07M	-12.13M	-12.58M	-15.65M	-16.49M	-26.60M	-18.97M	-9.61M	-16.63M	-12.49M	-12.35M	-13.09M	-20.19M	-16.64M	-12.84M	-19.22M	-42.20M	-30.36M	-27.36M	4.50M	-42.97M	-35.97M	-1.27M	-40.57M	-45.68M	-47.15M	-47.60M	-37.56M	-43.92M	-43.09M	-53.12M	-51.71M	21.33M	-120.77M	-102.89M	-60.57M	-48.99M	-36.05M	10.76M	-23.82M	-30.48M	-19.96M	-35.09M
Tax Provisions																									-0.75M		-3.34M	-1.64M		-0.02M	-0.00M	0.01M															0.24M	0.11M	0.26M	0.02M	0.10M	-0.09M	0.10M	0.08M	0.03M	0.23M	0.19M	-6.26M	1.27M	-0.27M	0.10M	0.07M	0.09M	-0.43M	0.12M	0.03M	-0.16M
Profit After Tax	6.83M	4.51M	-4.85M	-34.78M	-3.98M	3.86M	-8.70M	-8.32M	9.58M	-10.28M	-9.57M	-6.37M	-7.27M	-5.73M	-5.79M	-3.48M	-6.88M	-5.45M	-6.14M	-8.14M	-7.57M	-6.98M	-7.54M	-4.32M	-5.32M	-12.13M	-9.24M	-14.01M	-16.49M	-26.57M	-18.96M	-9.62M	-16.63M	-12.49M	-12.35M	-13.09M	-20.19M	-16.64M	-12.84M	-19.22M	-42.20M	-30.36M	-27.36M	4.55M	-42.97M	-35.97M	-1.55M	-40.67M	-45.94M	-47.17M	-47.69M	-37.50M	-43.98M	-43.17M	-53.16M	-51.97M	21.13M	-114.51M	-104.16M	-60.30M	-49.09M	-36.13M	10.67M	-23.40M	-30.60M	-19.99M	-34.93M
Income from Non-Controlling Interests																																								-0.56M	-0.05M	-0.07M	-0.05M	-0.05M	-0.06M	-0.04M	0.04M	-0.07M	-0.01M	-0.01M
Income from Continuing Operations	-6.83M	-4.51M	-4.85M	-2.42M	-3.98M	-3.86M	-8.70M	-8.34M	-9.58M	-10.28M	-9.57M	-6.37M	-7.27M	-5.73M	-5.79M	-3.37M	-6.88M	-5.45M	-6.14M	-8.17M	-7.57M	-6.98M	-7.54M	-4.32M	-5.32M	-12.13M	-9.24M	-14.01M	-16.49M	-26.57M	-18.96M	-9.62M	-16.63M	-12.49M	-12.35M	-13.09M	-20.19M	-16.64M	-12.84M	-19.22M	-42.20M	-30.36M	-27.36M	4.50M	-42.97M	-35.97M	-1.51M	-40.67M	-45.94M	-47.17M	-47.70M	-37.47M	-44.02M	-43.17M	-53.16M	-51.94M	21.13M	-114.51M	-104.16M	-60.30M	-49.09M	-36.13M	10.67M	-23.40M	-30.60M	-19.99M	-34.93M
Consolidated Net Income	-6.83M	-4.51M	-4.85M	-2.42M	-3.98M	-3.86M	-8.70M	-8.34M	-9.58M	-10.28M	-9.57M	-6.37M	-7.27M	-5.73M	-5.79M	-3.37M	-6.88M	-5.45M	-6.14M	-8.17M	-7.57M	-6.98M	-7.54M	-4.32M	-5.32M	-12.13M	-9.24M	-14.01M	-16.49M	-26.57M	-18.96M	-9.62M	-16.63M	-12.49M	-12.35M	-13.09M	-20.19M	-16.64M	-12.84M	-19.22M	-42.20M	-30.36M	-27.36M	4.50M	-42.97M	-35.97M	-1.51M	-40.67M	-45.94M	-47.17M	-47.70M	-37.47M	-44.02M	-43.17M	-53.16M	-51.94M	21.13M	-114.51M	-104.16M	-60.30M	-49.09M	-36.13M	10.67M	-23.40M	-30.60M	-19.99M	-34.93M
Income towards Parent Company	-6.83M	-4.51M	-4.85M	-2.42M	-3.98M	-3.86M	-8.70M	-8.34M	-9.58M	-10.28M	-9.57M	-6.37M	-7.27M	-5.73M	-5.79M	-3.37M	-6.88M	-5.45M	-6.14M	-8.17M	-7.57M	-6.98M	-7.54M	-4.32M	-5.32M	-12.13M	-9.24M	-14.01M	-16.49M	-26.57M	-18.96M	-9.62M	-16.63M	-12.49M	-12.35M	-13.09M	-20.19M	-16.64M	-12.84M	-19.22M	-42.20M	-30.36M	-27.36M	4.50M	-42.97M	-35.97M	-1.51M	-40.67M	-45.94M	-47.17M	-47.70M	-37.47M	-44.02M	-43.17M	-53.16M	-51.94M	21.13M	-114.51M	-104.16M	-60.30M	-49.09M	-36.13M	10.67M	-23.40M	-30.60M	-19.99M	-34.93M
Preferred Dividend Payments																																																															1.29M
Net Income towards Common Stockholders	-6.83M	-4.51M	-4.85M	-2.42M	-3.98M	-3.86M	-8.70M	-8.34M	-9.58M	-10.28M	-9.57M	-6.37M	-7.27M	-5.73M	-5.79M	-3.37M	-6.88M	-5.45M	-6.14M	-8.17M	-7.57M	-6.98M	-7.54M	-4.32M	-5.32M	-12.13M	-9.24M	-14.01M	-16.49M	-26.57M	-18.96M	-9.62M	-16.63M	-12.49M	-12.35M	-13.09M	-20.19M	-16.64M	-12.84M	-19.22M	-42.20M	-30.36M	-27.36M	4.50M	-42.97M	-35.97M	-1.51M	-40.67M	-45.94M	-47.17M	-47.69M	-37.47M	-44.02M	-43.17M	-53.16M	-51.94M	21.13M	-114.51M	-104.16M	-60.30M	-49.09M	-36.13M	9.38M	-23.40M	-30.60M	-19.99M	-34.93M
Additional items
EPS (Basic)	-0.04M	-0.02M	-0.01M	-0.06	-0.04M	-0.09	-0.19	-0.18	-0.05M	-0.20	-0.18	-0.13	-0.13	-0.11	-0.11	-0.06	-0.13	-0.10	-0.11	-0.15	-0.12	-0.10	-0.11	-0.06	-0.08	-0.17	-0.13	-0.20	-0.23	-0.38	-0.27	-0.14	-0.23	-0.17	-0.15	-0.17	-0.23	-0.17	-0.13	-0.20	-0.41	-0.26	-0.24	0.04	-0.37	-0.26	-0.01	-0.30	-0.32	-0.33	-0.33	-0.25	-0.30	-0.29	-0.34	-0.34	0.13	-0.66	-0.59	-0.35	-0.27	-0.18	0.05	-0.12	-0.14	-0.08	-0.11
EPS (Weighted Average and Diluted)																																												0.04		-0.26	-0.01	-0.29	-0.32	-0.33	-0.33	-0.25	-0.30	-0.29	-0.34	-0.34	0.12	-0.66	-0.59	-0.35	-0.27	-0.18	0.04	-0.12	-0.14	-0.08	-0.11
Shares Outstanding (Weighted Average)	170.00	280.00	390.00	42.05M	90.00	45.16M	45.20M	45.17M	210.00	51.50M	52.46M	50.51M	52.57M	52.66M	52.77M	52.74M	53.38M	53.79M	54.79M	55.97M	63.20M	67.98M	68.23M	67.02M	69.28M	69.68M	69.89M	69.76M	70.37M	70.49M	70.62M	70.55M	71.03M	72.53M	83.75M	78.08M	86.33M	97.27M	101.72M	96.94M	102.27M	114.38M	115.71M	112.11M	116.06M	138.98M	141.10M	134.45M	143.11M	143.98M	145.40M	144.57M	146.22M	148.16M	158.04M	154.34M	168.53M	174.32M	177.17M	174.44M	180.34M	203.95M	208.34M	201.70M	220.30M	257.00M	304.30M
Shares Outstanding (Diluted Average)																																												112.11M		138.98M	141.10M	134.45M	143.11M	143.98M	145.40M	144.57M	146.22M	148.16M	158.04M	154.34M	169.18M	174.32M	177.17M	174.44M	180.34M	203.95M	214.32M	201.70M	220.30M	257.00M	304.30M
EBITDA	-7.03M	-5.16M	-4.80M	-2.42M	-4.00M	-3.88M	-8.71M	-8.34M	-9.60M	-10.28M	-9.57M	-6.37M	-7.28M	-5.74M	-5.80M	-3.37M	-6.91M	-5.47M	-6.16M	-8.17M	-7.61M	-7.05M	-7.65M	-4.47M	-6.22M	-12.28M	-12.69M	-15.67M	-16.68M	-26.84M	-19.21M	-9.83M	-16.79M	-12.77M	-13.04M	-13.77M	-21.00M	-19.14M	-16.24M	-20.77M	-43.90M	-33.50M	-29.25M	1.47M	-44.52M	-37.90M	-3.70M	-43.43M	-46.30M	-48.70M	-48.44M	-39.90M	-45.26M	-45.73M	-54.89M	-55.39M	18.03M	-123.57M	-106.41M	-62.06M	-51.53M	-37.08M	10.63M	-25.99M	-29.63M	-17.86M	-35.55M
Tax Rate																									12.33%		26.53%	10.45%		0.09%	0.02%	-0.14%															-18.65%	-0.27%	-0.57%	-0.05%	-0.21%	0.25%	-0.23%	-0.19%	-0.06%	-0.44%	0.91%	5.19%	-1.23%	0.45%	-0.20%	-0.21%	0.82%	1.79%	-0.39%	-0.14%	0.46%

Research Tools

Sangamo Therapeutics Income Statement (2009-2025) | SGMO

Create an account

Sign In

Reset Password